🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 7 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/05/2020 36,90 36,96 33,55 33,71 -5,55% 9,23% 1.116.600
22/05/2020 35,65 35,85 34,80 35,69 -0,42% 2,95% 587.600
21/05/2020 36,57 36,82 34,77 35,84 -2,16% 5,61% 972.400
20/05/2020 36,87 37,39 36,01 36,63 +0,38% 3,74% 1.025.100
19/05/2020 38,30 38,96 36,44 36,49 -4,58% 6,58% 1.097.500
18/05/2020 36,96 38,96 36,62 38,24 +6,67% 6,34% 1.403.000
15/05/2020 35,82 36,32 34,41 35,85 +0,70% 5,33% 963.000
14/05/2020 33,36 36,01 32,66 35,60 +4,23% 10,04% 1.455.600
13/05/2020 36,41 37,25 33,51 34,16 -4,97% 10,27% 1.158.100
12/05/2020 36,42 38,16 35,03 35,94 -0,99% 8,59% 1.386.200
11/05/2020 33,87 37,29 33,33 36,30 +6,33% 11,68% 1.522.100
08/05/2020 36,48 37,10 33,30 34,14 -2,82% 10,42% 1.767.900
07/05/2020 34,95 35,44 33,77 35,13 +2,63% 4,79% 1.251.800
06/05/2020 35,71 35,87 34,06 34,23 -3,31% 5,07% 827.100
05/05/2020 35,11 36,33 34,69 35,40 +3,63% 4,67% 1.340.000
04/05/2020 31,89 34,24 31,72 34,16 +4,91% 7,90% 1.030.600
01/05/2020 33,55 34,27 31,50 32,56 -5,43% 8,26% 1.296.400
30/04/2020 36,18 36,38 34,40 34,43 -5,75% 5,47% 1.293.200
29/04/2020 38,34 38,38 36,36 36,53 -1,96% 5,27% 929.800
28/04/2020 40,00 40,01 37,15 37,26 -5,60% 7,15% 873.600
27/04/2020 39,21 40,00 38,92 39,47 +1,49% 2,75% 671.900
24/04/2020 38,95 39,35 37,70 38,89 +1,14% 4,23% 1.003.200
23/04/2020 36,85 39,39 36,85 38,45 +4,09% 6,89% 1.045.500
22/04/2020 37,94 37,94 36,08 36,94 +0,87% 4,90% 1.030.600
21/04/2020 37,72 38,66 36,17 36,62 -5,84% 6,60% 1.306.400
20/04/2020 35,72 40,02 35,72 38,89 +6,40% 12,04% 1.824.400
17/04/2020 35,98 36,64 35,09 36,55 +4,94% 4,31% 1.258.700
16/04/2020 35,07 35,44 33,05 34,83 -1,42% 6,81% 1.819.700
15/04/2020 36,86 37,23 34,41 35,33 -3,92% 7,65% 1.832.500
14/04/2020 35,90 37,55 35,10 36,77 +5,51% 6,82% 1.366.100